We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$65.1B
AUM Growth
+$4.63B
Cap. Flow
+$746M
Cap. Flow %
1.15%
Top 10 Hldgs %
9.56%
Holding
3,794
New
469
Increased
1,367
Reduced
1,237
Closed
370

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$354M
2
WFC icon
Wells Fargo
WFC
+$274M
3
IBM icon
IBM
IBM
+$266M
4
QCOM icon
Qualcomm
QCOM
+$257M
5
MDLZ icon
Mondelez International
MDLZ
+$224M

Sector Composition

Rank Sector Weight
1 Technology 13.61%
2 Healthcare 10.26%
3 Consumer Discretionary 10.07%
4 Financials 8.17%
5 Communication Services 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMS icon
1951
Fresenius Medical Care
FMS
$13.4B
$2.09M ﹤0.01%
+42,833
New +$2.04M
PRTH icon
1952
Priority Technology Holdings
PRTH
$538M
$2.09M ﹤0.01%
205,000
ABCO
1953
DELISTED
Advisory Board Co
ABCO
$2.09M ﹤0.01%
38,973
-128,930
-77% -$6.95M
XNCR icon
1954
Xencor
XNCR
$1.47B
$2.09M ﹤0.01%
91,012
+38,141
+72% +$847K
HLI icon
1955
Houlihan Lokey
HLI
$9.75B
$2.08M ﹤0.01%
53,290
-34,089
-39% -$1.25M
MRTN icon
1956
Marten Transport
MRTN
$1.26B
$2.08M ﹤0.01%
152,198
-5,825
-4% -$66.1K
PHUN icon
1957
Phunware
PHUN
$43.1M
$2.08M ﹤0.01%
4,100
PBR icon
1958
Petrobras
PBR
$116B
$2.08M ﹤0.01%
207,035
-248,538
-55% -$2.26M
THR
1959
DELISTED
Thermon Group Holdings
THR
$2.08M ﹤0.01%
115,571
-2,677
-2% -$46.9K
INGR icon
1960
Ingredion
INGR
$6.4B
$2.07M ﹤0.01%
17,189
-22,593
-57% -$2.75M
ONC
1961
BeOne Medicines Ltd
ONC
$33.8B
$2.07M ﹤0.01%
+20,039
New +$1.49M
ROG icon
1962
CALL
Rogers Corp
ROG
$2.31B
$2.07M ﹤0.01%
+15,500
New +$1.84M
TAST
1963
DELISTED
Carrols Restaurant Group, Inc.
TAST
$2.07M ﹤0.01%
189,562
+74,850
+65% +$869K
NE
1964
DELISTED
Noble Corporation
NE
$2.07M ﹤0.01%
449,297
-1,354,998
-75% -$5.09M
EDU icon
1965
PUT
New Oriental
EDU
$7.94B
$2.06M ﹤0.01%
23,400
PARA
1966
DELISTED
Paramount Global Class B
PARA
$2.06M ﹤0.01%
35,599
-56,829
-61% -$3.59M
KTWO
1967
DELISTED
K2M Group Holdings, Inc
KTWO
$2.06M ﹤0.01%
+96,989
New +$2.25M
TRIP icon
1968
PUT
TripAdvisor
TRIP
$1.66B
$2.06M ﹤0.01%
50,700
-6,700
-12% -$272K
CTT
1969
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$2.04M ﹤0.01%
161,638
+14,503
+10% +$169K
MT icon
1970
PUT
ArcelorMittal
MT
$50.9B
$2.04M ﹤0.01%
79,100
+53,200
+205% +$1.38M
MRO
1971
CALL
DELISTED
Marathon Oil Corporation
MRO
$2.04M ﹤0.01%
+150,300
New +$1.78M
DBD
1972
DELISTED
Diebold Nixdorf Incorporated
DBD
$2.03M ﹤0.01%
+89,009
New +$1.9M
ARRY
1973
DELISTED
Array Biopharma Inc
ARRY
$2.03M ﹤0.01%
+164,933
New +$1.53M
GIS icon
1974
General Mills
GIS
$19.5B
$2.02M ﹤0.01%
39,114
-739,872
-95% -$40.6M
CUK
1975
DELISTED
Carnival PLC
CUK
$2.02M ﹤0.01%
+31,396
New +$2.11M

Similar funds

D.E. Shaw & Co's Q3 2017 Portfolio in Review

As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
  • D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
  • D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
  • D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
  • D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
  • D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
  • D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.

Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.